Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
Titel:
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
Auteur:
Fasching, Peter A. Decker, Thomas Hartkopf, Andreas Nusch, Arnd Heinrich, Bernhard J. Kurbacher, Christian Fuchs, Roswitha Tesch, Hans Krabisch, Petra Huober, Jens Kuemmel, Sherko Brucker, Sara Janni, Wolfgang Schneeweiss, Andreas Schuler, Martin Fehm, Tanja Lüftner, Diana Quiering, Claudia Voges, Claudia Kreuzeder, Julia Reinisch, Mattea